Ritu Baral, an analyst from TD Cowen, maintained the Buy rating on Insmed (INSM – Research Report). The associated price target remains the ...

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Insmed (INSM – Research Report), with a price target of $98.00.

We recently compiled a list of the 10 Best Russell 2000 Stocks to Invest in According to Analysts. In this article, we are ...

Two pulmonologists were sued for malpractice but not held liable after failing to detect liver cancer in a patient being treated for cough.

Goldman Sachs has flagged Insmed Inc. as a potential merger candidate under the pro-business policies of the incoming Donald ...

Dr Zaheer Mangera shares insights into the lung cancer pathway and the benefits and challenges of early diagnosis and lung ...

Love Island' has become increasingly diverse over the years. We look at ten memorable South Asian contestants from the show.

With asthma, the lining of the lungs is altered, with a tendency toward inflammation ... High Frequency Chest Wall Oscillation May Decrease Moderate Exacerbations in Subjects With Bronchiectasis, COPD ...

Jon Harvey, a four-time state wrestling qualifier, was in a medically induced coma 11 months ago. He's now making the most of ...

Jan. 13, 2025 — Scientists have found that a test to detect circulating tumor DNA can predict lung cancer ... Lung Cancer Test Predicts Survival in Early Stages Better Than Current Methods Jan ...

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S. Centers for Disease Control ...